Instrument Inactif

Autres langues Concordia International Corp Nasdaq

Actions

CA2065191009

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

2023	ADVANZ PHARMA Corp. Limited a finalisé l'acquisition des droits mondiaux de Tostran auprès de Kyowa Kirin Co, Ltd. (TSE:4151).	CI
2023	Alvotech et Advanz Pharma étendent leur partenariat stratégique pour la commercialisation de cinq candidats biosimilaires en Europe	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

ADVANZ PHARMA Corp. Limited announced that it has received funding from Nordic Capital, Ontario Teachers' Pension Plan Board	26/02
ADVANZ PHARMA Corp. Limited signed an agreement to acquire Global rights of Androcur.	07/11
ADVANZ PHARMA Corp. Limited completed the acquisition of Global rights of Tostran from Kyowa Kirin Co., Ltd..	18/10/23
Alvotech and Advanz Pharma Extend Strategic Partnership to Commercialize Five Proposed Biosimilars in Europe	24/05/23
ADVANZ PHARMA Corp. Limited signed an agreement to acquire Global rights of Tostran from Kyowa Kirin Co., Ltd..	25/04/23
Applied Therapeutics, Inc. Announces Partnership with Advanz Pharma for Commercialization of AT-007 in Europe	04/01/23
ADVANZ PHARMA further strengthens its specialty and hospital business by acquiring an anti-infective portfolio from Sanofi	04/10/22
ADVANZ PHARMA Corp. Limited acquired Portfolio Of Generic Drugs Of Sanofi.	03/10/22
ADVANZ PHARMA to receive exclusive rights from PolyPid to commercialize D-PLEX100 in Europe	04/08/22
INTERCEPT ANNOUNCES CLOSING OF TRANSACTION WITH ADVANZ PHARMA TO TRANSFER RIGHTS TO COMMERCIALIZE OCALIVA FOR PBC OUTSIDE THE U.S.	04/07/22
ADVANZ PHARMA completes acquisition of Intercept's business in Europe, Canada, and all other markets outside of the U.S.	04/07/22
ADVANZ PHARMA Corp. Limited Limited Names Susanna El-Armale as Chief Corporate Development Officer	01/04/22
ADVANZ PHARMA Corp. Limited Names Andreas Stickler as New CFO	01/04/22
Steffen Wagner Assumes His Position as New Chief Executive Officer At ADVANZ PHARMA Corp. Limited	01/04/22
Steffen Wagner assumes his position as new Chief Executive Officer at ADVANZ PHARMA	01/04/22
ADVANZ PHARMA launches its first Environmental, Social and Governance report	10/12/21
ADVANZ PHARMA makes key changes to senior leadership to further accelerate next phase of growth	18/11/21
ADVANZ PHARMA Corp. Limited Announces Executive Changes	18/11/21
ADVANZ PHARMA Corp. Limited Announces Executive Changes	18/11/21
ADVANZ PHARMA Corp. Limited Announces Executive Changes	18/11/21

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Concordia International Corp Nasdaq

Actions

CA2065191009

Autres langues

Filtres